Similarly, assessment of cell motility and invasion in wound-healing and TranswellTM assays revealed that KCTD9 overexpression inhibited the metastatic potential of CRC cells (Fig. 3D–G). This evidence concerns the gene KCTD9 and colorectal carcinoma.